Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Endologix Inc (ELGX) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 511,860
  • Shares Outstanding, K 82,370
  • Annual Sales, $ 153,610 K
  • Annual Income, $ -50,420 K
  • 36-Month Beta 0.91
  • Price/Sales 2.77
  • Price/Book 3.83

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.78 +28.35%
on 12/28/16
6.90 -11.09%
on 01/17/17
-1.05 (-14.67%)
since 12/23/16
3-Month
4.78 +28.35%
on 12/28/16
12.74 -51.84%
on 10/24/16
-6.34 (-50.80%)
since 10/21/16
52-Week
4.78 +28.35%
on 12/28/16
14.49 -57.66%
on 07/12/16
-1.61 (-20.84%)
since 01/22/16

Most Recent Stories

More News
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Endologix, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 6, 2017 - ELGX

The following statement is being issued by Levi & Korsinsky, LLP:

IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces an Investigation of Endologix, Inc. and Encourages Investors to Contact the Firm

IRVINE, CA / ACCESSWIRE / January 20, 2017 / Khang & Khang LLP (the "Firm") announces that it is investigating claims against Endologix, Inc. ("Endologix" or the "Company") (NASDAQ: ELGX) concerning possible...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endologix, Inc. of Class Action Lawsuit and Upcoming Deadline - ELGX

Pomerantz LLP announces that a class action lawsuit has been filed against Endologix, Inc. ("Endologix" or the "Company") (NASDAQ: ELGX) and certain of its officers. The class action, filed in United States...

The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Endologix, Inc. Investors and Encourages Investors to Contact the Firm

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Endologix, Inc. ("Endologix" or the "Company") (NASDAQ: ELGX)...

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces a Class Action Lawsuit Against Endologix, Inc. and Advises Investors with Losses to Contact the Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating Endologix, Inc. ("Endologix" or the "Company") (Nasdaq: ELGX) concerning possible...

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Endologix, Inc. and Encourages Investors to Contact the Firm

IRVINE, CA / ACCESSWIRE / January 18, 2017 / Khang & Khang LLP (the "Firm") announces that it is investigating claims against Endologix, Inc. ("Endologix" or the "Company") (NASDAQ: ELGX) concerning possible...

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Endologix, Inc. - ELGX

Rosen Law Firm, a global investor rights law firm, announces that the filing of a class action lawsuit on behalf of purchasers of Endologix, Inc. securities (NASDAQ:ELGX) from August 2, 2016 through November...

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Endologix, Inc. and Encourages Investors to Contact the Firm

IRVINE, CA / ACCESSWIRE / January 18, 2017 / Khang & Khang LLP (the "Firm") announces that it is investigating claims against Endologix, Inc. ("Endologix" or the "Company") (NASDAQ: ELGX) concerning possible...

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Endologix Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central...

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Endologix Inc. (ELGX) and Lead Plaintiff Deadline: March 6, 2017

NEW YORK, NY / ACCESSWIRE / January 17, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Endologix Inc. ("Endologix" or the "Company") (NASDAQ:...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Endologix, Inc. develops, manufactures and markets products for the treatment of coronary and vascular diseases. A leader in the emerging field of vascular brachytherapy, Endologix, has developed a unique method for the delivery of radiation to prevent restenosis following the interventional treatment...

See More

Support & Resistance

2nd Resistance Point 6.37
1st Resistance Point 6.23
Last Price 6.14
1st Support Level 5.98
2nd Support Level 5.87

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.